Daniela Araiza‐Olivera
ORCID: 0000-0002-8207-9765Also affiliated with Temple University Health System
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 7 papers. Top paper: “PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2)”.
Jeffrey R. Gehlhausen, Sofiia Karchugina, Hoi-Yee Chow, Daniela Araiza‐Olivera, Maria Radu +14 more
Carlos Herrera-Montávez, Sara Montserrat‐Sangrà, Daniela Araiza‐Olivera, Jianping Hu, Ryan Neumann-Domer +6 more
Konstantin Budagyan, Cristina Uribe‐Alvarez, Alison Kurimchak, Daniela Araiza‐Olivera, Kathy Q. Cai +5 more
Alexa C. Cannon, Konstantin Budagyan, Cristina Uribe‐Alvarez, Alison Kurimchak, Daniela Araiza‐Olivera +5 more
Konstantin Budagyan, Cristina Uribe‐Alvarez, Alison Kurimchak, Daniela Araiza‐Olivera, Kathy Q. Cai +5 more
Alexa C. Cannon, Adam Chatoff, Dorothy Benton, Alison Kurimchak, Daniela Araiza‐Olivera +6 more
Tatiana Y. Prudnikova, Cristina Uribe‐Alvarez, Kathy Q. Cai, Janusz Franco‐Barraza, Jesús M. Dones +3 more